CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C03704 | BRD-K04111260 | raclopride | DRD2; DRD3 | Dopamine receptor antagonist | -- | Details |
C03705 | BRD-K04112579 | nepafenac | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
C03706 | BRD-K04116560 | BRD-K04116560 | -- | -- | -- | Details |
C03707 | BRD-K04117492 | BRD-K04117492 | -- | -- | -- | Details |
C03708 | BRD-K04123911 | BRD-K04123911 | -- | -- | -- | Details |
C03709 | BRD-K04124609 | BRD-K04124609 | -- | -- | -- | Details |
C03710 | BRD-K04133968 | BRD-K04133968 | -- | -- | -- | Details |
C03711 | BRD-K04136539 | BRD-K04136539 | -- | -- | -- | Details |
C03712 | BRD-K04139743 | BRD-K04139743 | -- | -- | -- | Details |
C03713 | BRD-K04143388 | BRD-K04143388 | -- | -- | -- | Details |
C03714 | BRD-K04143779 | BRD-K04143779 | -- | -- | -- | Details |
C03715 | BRD-K04146668 | GW-441756 | NTRK1 | Growth factor receptor inhibitor | -- | Details |
C03716 | BRD-K04147035 | BRD-K04147035 | -- | -- | -- | Details |
C03717 | BRD-K04147413 | BRD-K04147413 | -- | -- | -- | Details |
C03718 | BRD-K04153348 | BRD-K04153348 | -- | -- | -- | Details |
C03719 | BRD-K04155570 | BRD-K04155570 | -- | -- | -- | Details |
C03720 | BRD-K04156788 | BRD-K04156788 | -- | -- | -- | Details |
C03721 | BRD-K04163641 | BRD-K04163641 | -- | -- | -- | Details |
C03722 | BRD-K04170657 | psoromic-acid | -- | -- | -- | Details |
C03723 | BRD-K04181823 | BRD-K04181823 | -- | -- | -- | Details |
C03724 | BRD-K04185004 | oxybuprocaine | -- | -- | -- | Details |
C03725 | BRD-K04188046 | BRD-K04188046 | -- | -- | -- | Details |
C03726 | BRD-K04192407 | BRD-K04192407 | -- | -- | -- | Details |
C03727 | BRD-K04192660 | BRD-K04192660 | -- | -- | -- | Details |
C03728 | BRD-K04195898 | BRD-K04195898 | -- | -- | -- | Details |
C03729 | BRD-K04196669 | BRD-K04196669 | -- | -- | -- | Details |
C03730 | BRD-K04196797 | oxcarbazepine | SCN1A; SCN3A; SCN5A | Sodium channel blocker | -- | Details |
C03731 | BRD-K04206413 | BRD-K04206413 | -- | -- | -- | Details |
C03732 | BRD-K04210847 | tamoxifen | ESR1; ESR2 | Estrogen receptor antagonist; Selective estrogen receptor modulator | -- | Details |
C03733 | BRD-K04218075 | clomifene | ESR1 | Estrogen receptor antagonist | -- | Details |
C03734 | BRD-K04219533 | BRD-K04219533 | -- | -- | -- | Details |
C03735 | BRD-K04229162 | BRD-K04229162 | -- | -- | -- | Details |
C03736 | BRD-K04230416 | BRD-K04230416 | -- | -- | -- | Details |
C03737 | BRD-K04232710 | BRD-K04232710 | -- | -- | -- | Details |
C03738 | BRD-K04237106 | BRD-K04237106 | -- | -- | -- | Details |
C03739 | BRD-K04238122 | BRD-K04238122 | -- | -- | -- | Details |
C03740 | BRD-K04238564 | BRD-K04238564 | -- | -- | -- | Details |
C03741 | BRD-K04239420 | BRD-K04239420 | -- | -- | -- | Details |
C03742 | BRD-K04251331 | BRD-K04251331 | -- | -- | -- | Details |
C03743 | BRD-K04251837 | BRD-K04251837 | -- | -- | -- | Details |
C03744 | BRD-K04254463 | paraquat | -- | -- | -- | Details |
C03745 | BRD-K04257723 | BRD-K04257723 | -- | -- | -- | Details |
C03746 | BRD-K04260462 | BRD-K04260462 | -- | -- | -- | Details |
C03747 | BRD-K04261044 | BRD-K04261044 | -- | -- | -- | Details |
C03748 | BRD-K04262969 | BRD-K04262969 | -- | -- | -- | Details |
C03749 | BRD-K04264130 | favipiravir | -- | -- | -- | Details |
C03750 | BRD-K04266880 | BRD-K04266880 | -- | -- | -- | Details |
C03751 | BRD-K04267190 | BRD-K04267190 | -- | -- | -- | Details |
C03752 | BRD-K04269696 | BRD-K04269696 | -- | -- | -- | Details |
C03753 | BRD-K04272258 | BRD-K04272258 | -- | -- | -- | Details |
C03754 | BRD-K04275703 | BRD-K04275703 | -- | -- | -- | Details |
C03755 | BRD-K04278887 | BRD-K04278887 | -- | -- | -- | Details |
C03756 | BRD-K04279026 | BRD-K04279026 | -- | -- | -- | Details |
C03757 | BRD-K04284624 | BRD-K04284624 | -- | -- | -- | Details |
C03758 | BRD-K04288183 | BRD-K04288183 | -- | -- | -- | Details |
C03759 | BRD-K04289865 | BRD-K04289865 | -- | -- | -- | Details |
C03760 | BRD-K04291521 | BRD-K04291521 | -- | -- | -- | Details |
C03761 | BRD-K04309313 | BRD-K04309313 | -- | -- | -- | Details |
C03762 | BRD-K04317371 | BRD-K04317371 | -- | -- | -- | Details |
C03763 | BRD-K04321001 | BRD-K04321001 | -- | -- | -- | Details |
C03764 | BRD-K04325154 | BRD-K04325154 | -- | -- | -- | Details |
C03765 | BRD-K04326190 | BRD-K04326190 | -- | -- | -- | Details |
C03766 | BRD-K04328580 | BRD-K04328580 | -- | -- | -- | Details |
C03767 | BRD-K04336022 | BRD-K04336022 | -- | -- | -- | Details |
C03768 | BRD-K04340915 | BRD-K04340915 | -- | -- | -- | Details |
C03769 | BRD-K04358482 | BRD-K04358482 | -- | -- | -- | Details |
C03770 | BRD-K04361415 | BRD-K04361415 | -- | -- | -- | Details |
C03771 | BRD-K04362735 | BRD-K04362735 | -- | -- | -- | Details |
C03772 | BRD-K04363234 | BRD-K04363234 | -- | -- | -- | Details |
C03773 | BRD-K04363266 | BRD-K04363266 | -- | -- | -- | Details |
C03774 | BRD-K04364654 | BRD-K04364654 | -- | -- | -- | Details |
C03775 | BRD-K04365932 | BRD-K04365932 | -- | -- | -- | Details |
C03776 | BRD-K04366109 | BRD-K04366109 | -- | -- | -- | Details |
C03777 | BRD-K04366697 | BRD-K04366697 | -- | -- | -- | Details |
C03778 | BRD-K04367224 | BRD-K04367224 | -- | -- | -- | Details |
C03779 | BRD-K04367289 | BRD-K04367289 | -- | -- | -- | Details |
C03780 | BRD-K04368295 | benzofuran | -- | -- | -- | Details |
C03781 | BRD-K04371396 | BRD-K04371396 | -- | -- | -- | Details |
C03782 | BRD-K04371509 | BRD-K04371509 | -- | -- | -- | Details |
C03783 | BRD-K04371719 | BRD-K04371719 | -- | -- | N,N'-Di-m-tolyl-ethane-1,2-diamine | Details |
C03784 | BRD-K04378630 | BRD-K04378630 | -- | -- | -- | Details |
C03785 | BRD-K04380254 | BRD-K04380254 | -- | -- | -- | Details |
C03786 | BRD-K04388421 | BRD-K04388421 | -- | -- | -- | Details |
C03787 | BRD-K04389336 | labetalol | ADRA1D; ADRA1A; ADRB1; ADRB2 | Adrenergic receptor antagonist | -- | Details |
C03788 | BRD-K04394237 | drospirenone | NR3C2; PGR | Mineralocorticoid receptor antagonist | -- | Details |
C03789 | BRD-K04395157 | BRD-K04395157 | -- | -- | -- | Details |
C03790 | BRD-K04399953 | BRD-K04399953 | -- | -- | -- | Details |
C03791 | BRD-K04402444 | BRD-K04402444 | -- | -- | -- | Details |
C03792 | BRD-K04407772 | BRD-K04407772 | -- | -- | -- | Details |
C03793 | BRD-K04408214 | BRD-K04408214 | -- | -- | -- | Details |
C03794 | BRD-K04409515 | BRD-K04409515 | -- | -- | -- | Details |
C03795 | BRD-K04411796 | BRD-K04411796 | -- | -- | -- | Details |
C03796 | BRD-K04412738 | tramadol | OPRM1; SLC6A2; SLC6A4 | Opioid receptor agonist; Serotonin reuptake inhibitor; Norepinephrine reputake inhibitor | -- | Details |
C03797 | BRD-K04414442 | SB-222200 | TACR3 | Tachykinin antagonist | -- | Details |
C03798 | BRD-K04418684 | BRD-K04418684 | -- | -- | -- | Details |
C03799 | BRD-K04424176 | BRD-K04424176 | -- | -- | -- | Details |
C03800 | BRD-K04426746 | BRD-K04426746 | -- | -- | -- | Details |
C03801 | BRD-K04429417 | BRD-K04429417 | -- | -- | -- | Details |
C03802 | BRD-K04430056 | 7-nitroindazole | -- | -- | 7-NITROINDAZOLE | Details |
C03803 | BRD-K04431258 | Val-Val-Val | -- | -- | -- | Details |